Novo Nordisk Seeing Younger Diabetes Patients

May.05 -- Novo Nordisk A/S CEO Lars Fruergaard Jorgensen said that the number of younger diabetes patients is on the rise, which he attributed to childhood obesity. He speaks to Francine Lacqua on "Bloomberg Surveillance: Early Edition."

Popular Videos this Week

Minecraft Survival Let's Play